Transfer: Gabriel Jesus set for Barcelona medicals after Arsenal accept €10m fee

Author: Ifreke InyangPublished on: August 30, 2026Country: England

Sports

Transfer: Gabriel Jesus set for Barcelona medicals after Arsenal accept €10m fee

Arsenal striker Gabriel Jesus is set to join Barcelona in a €10m deal. Football transfer expert Fabrizio Romano revealed that Jesus will undergo medicals on Monday. The striker has been sidelined by Mikel Arteta at Arsenal and is now set to continue his career outside England.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Herba Guirassy: the Franco-Guinean winger is leaving Nantes for Young Boys

SportsFrance

Rodolph TOMEGAH•13m ago

Herba Guirassy: the Franco-Guinean winger is leaving Nantes for Young Boys

Franco-Guinean winger Herba Guirassy is set to leave FC Nantes to join Swiss club Young Boys. This transfer marks a turning point in the player's career, having been a key element of the Nantes team. Financial details of the agreement have not been disclosed, but Guirassy is expected to bring his experience and talent to the Swiss Super League.

Congo: Goal-Scoring Red Devil Knocks on Claude Le Roy's Door

SportsCongo

Merveil Wello•13m ago

Congo: Goal-Scoring Red Devil Knocks on Claude Le Roy's Door

The Congolese player, often referred to as a Red Devil, continues to impress with his goal-scoring ability. His recent performances have caught the attention of Claude Le Roy, the national team coach of Congo. The coach may consider including him in the team for upcoming competitions.

Tottenham: Pape Matar Sarr wants to leave

SportsUnited Kingdom

Rodolph TOMEGAH•13m ago

Tottenham: Pape Matar Sarr wants to leave

Pape Matar Sarr, the young midfielder from Tottenham, has expressed his desire to leave the club. Despite his potential, he has not received enough playing time and wishes to find a new team where he can thrive. Discussions regarding his transfer may intensify in the coming days.

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox

Learn more